Vorinostat can activate heat shock protein (hsp)90 hyperacetylation, diminish hsp90 binding to ERα, increase polyubiquitylation, and decrease ERα expression in ERα-positive BC cells, according to Fiskus et al. (Fiskus et al., 2007). Here, ESR1 is linked to breast cancer.